BioSensics

Digital health technologies for clinical research & trials. Gold standard wearable devices for monitoring physical activity, gait, balance, and falls.

[BioSensics @BioSensics]

One in three seniors dies with #Alzheimer's or another #dementia

[IAPRD @PRDAssociation]

Preop gait variability is a prognostic predictor of gait and balance in Parkinson disease patients with deep brain stimulation
Log in :
https://t.co/IjmmkyMXRq

[BioSensics @BioSensics]

Given the overall evidence for amyloid-centric #Alzheimers treatments, do you think #Lecanemab will prove effective? @biogen @EisaiUS

[Gideon Gil @GideonGil]

Here we go again. By the end of September, we will learn whether lecanemab, another Biogen and Eisai Alzheimer's treatment aimed at amyloid, can significantly slow cognitive decline. https://t.co/fmtmqVekzY via @statnews

[BioSensics @BioSensics]

Soda, breakfast cereal and frozen (processed) foods associated with long-term cognitive decline #alzheimers #dementia #AAIC22

https://t.co/yEoXtuZ48J

[BioSensics @BioSensics]

Iron Buildup in Brain Linked to Higher Risk for Movement Disorders.

Hemochromatosis gene mutation carriers have increased risk of developing #movementdisorders including #Parkinsons.

https://t.co/D7AYCcKsZP

[Medidata @Medidata]

#BREAKINGNEWS: Our Sensor Cloud has secured "Best Biometric Sensor Solution" in the 6th annual @MedTech_Awards program, which honors #Innovation in #DigitalHealth and #MedTech. This year's program attracted 3900+ nominations from 15+ countries. Read more: https://t.co/o2fOxqOzEB

[BioSensics @BioSensics]

#AlzheimersDisease is the most common neurodegenerative disorder (7M cases globally), followed by #Parkinsonsdisease

[Dan Schoonover @SchooneyTunes]

I had a great time meeting the fine folks at @OrphanConf @BioSensics

[BioSensics @BioSensics]

Thank you @OrphanConf for hosting a meaningful conference impacting patients of rare desease. looking forward to next time!

[Dan Schoonover @SchooneyTunes]

I had a great time meeting the fine folks at @OrphanConf @BioSensics

[Amy L @Amylindberg123]

But you look 👀 so healthy…they say

[BioSensics @BioSensics]

What is a #digitalbiomarker?

Objective, quantifiable, physiological, and behavioral measures collected by means of digital devices that are portable, wearable, implantable, or digestible.

https://t.co/FIvcOu4LUS

[BioSensics @BioSensics]

LEGSys was used in a new clinical study measuring motor performance in #Parkinson's patients. The study aimed to assess the feasibility of wearable devices in early detection of PD motor-cognitive decline: https://t.co/W0UVrnv1PK

Learn more about LEGSys: https://t.co/om2uMK8Lg4

[BioSensics @BioSensics]

Traditional #ALS assessments are largely subjective, and require in-clinic visits.

ALS study participant (Male, 72 years old, ALSFRS at baseline = 34) performs Spiral Tracing Assessment on BioDigit Home (link below for more)

https://t.co/IXIOf4tR4v

cc @ALSTDI @ALSAMA @ALSAMA

[BioSensics @BioSensics]

People with higher levels of antioxidants in their blood may be less likely to develop #dementia, according to a study published in Neurology

https://t.co/wujZvzllVy

[Michael Okun @MichaelOkun]

Have you changed your slides to reflect the new image of Parkinson's disease by Armstrong et. al. in JAMA Neurology? Time to retire the Gower's sketch.
https://t.co/36fW5GRGcx